CXCR4-directed theranostics in oncology and inflammation

  • Given its prominent role in inflammation and cancer biology, the C-X-C motif chemokine receptor 4 (CXCR4) has gained a lot of attention in the recent years. This review gives a short overview of the physiology and pathology of chemokines and chemokine receptors and then focuses on the current experience of targeting CXCR4, using radiolabeled receptor ligands suitable for positron emission tomography (PET) imaging, in both hematologic and solid malignancy as well as in inflammatory conditions. Additionally, CXCR4-directed endoradiotherapy (ERT) as a new treatment option is discussed.

Export metadata

Statistics

Number of document requests

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Malte Kircher, Peter Herhaus, Margret Schottelius, Andreas K. Buck, Rudolf A. Werner, Hans-Jürgen Wester, Ulrich Keller, Constantin LapaORCiDGND
URN:urn:nbn:de:bvb:384-opus4-629914
Frontdoor URLhttps://opus.bibliothek.uni-augsburg.de/opus4/62991
ISSN:0914-7187OPAC
ISSN:1864-6433OPAC
Parent Title (English):Annals of Nuclear Medicine
Publisher:Springer
Place of publication:Berlin
Type:Article
Language:English
Year of first Publication:2018
Publishing Institution:Universität Augsburg
Release Date:2019/10/01
Tag:General Medicine; Radiology Nuclear Medicine and imaging
Volume:32
Issue:8
First Page:503
Last Page:511
DOI:https://doi.org/10.1007/s12149-018-1290-8
Institutes:Medizinische Fakultät
Medizinische Fakultät / Universitätsklinikum
Medizinische Fakultät / Lehrstuhl für Nuklearmedizin
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Licence (German):CC-BY 4.0: Creative Commons: Namensnennung